1. Home
  2. NKTR vs BRLS Comparison

NKTR vs BRLS Comparison

Compare NKTR & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BRLS
  • Stock Information
  • Founded
  • NKTR 1990
  • BRLS 2019
  • Country
  • NKTR United States
  • BRLS Canada
  • Employees
  • NKTR N/A
  • BRLS N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BRLS
  • Sector
  • NKTR Health Care
  • BRLS
  • Exchange
  • NKTR Nasdaq
  • BRLS NYSE
  • Market Cap
  • NKTR 160.4M
  • BRLS 130.4M
  • IPO Year
  • NKTR 1994
  • BRLS N/A
  • Fundamental
  • Price
  • NKTR $0.72
  • BRLS $3.50
  • Analyst Decision
  • NKTR Strong Buy
  • BRLS
  • Analyst Count
  • NKTR 6
  • BRLS 0
  • Target Price
  • NKTR $4.92
  • BRLS N/A
  • AVG Volume (30 Days)
  • NKTR 1.9M
  • BRLS 18.2K
  • Earning Date
  • NKTR 05-08-2025
  • BRLS 05-20-2025
  • Dividend Yield
  • NKTR N/A
  • BRLS N/A
  • EPS Growth
  • NKTR N/A
  • BRLS N/A
  • EPS
  • NKTR N/A
  • BRLS N/A
  • Revenue
  • NKTR $87,248,000.00
  • BRLS $26,619,131.00
  • Revenue This Year
  • NKTR N/A
  • BRLS N/A
  • Revenue Next Year
  • NKTR N/A
  • BRLS N/A
  • P/E Ratio
  • NKTR N/A
  • BRLS N/A
  • Revenue Growth
  • NKTR N/A
  • BRLS N/A
  • 52 Week Low
  • NKTR $0.43
  • BRLS $3.00
  • 52 Week High
  • NKTR $1.52
  • BRLS $9.50
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 54.57
  • BRLS 22.12
  • Support Level
  • NKTR $0.61
  • BRLS $3.00
  • Resistance Level
  • NKTR $0.74
  • BRLS $6.10
  • Average True Range (ATR)
  • NKTR 0.06
  • BRLS 0.34
  • MACD
  • NKTR 0.01
  • BRLS -0.25
  • Stochastic Oscillator
  • NKTR 81.79
  • BRLS 16.13

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

Share on Social Networks: